T cells in the pathogenesis of ANCA-associated vasculitis: current knowledge

Area of Science:

• Immunology
• Rheumatology
• Pathogenesis of Vasculitis

Background:

• Anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) are systemic immune-mediated diseases strongly linked to ANCA.
• Emerging evidence suggests ANCA may directly trigger AAV pathogenesis.
• Cell-mediated immunity, particularly T-cell activation, is prominent at inflammation sites in AAV patients.

Purpose of the Study:

• To review recent findings on the contribution of T cells to pathogenic processes in AAV.
• To emphasize the roles of Th1/Th2 cells, T-regulatory cells, and effector memory T cells in AAV pathogenesis.

Main Methods:

• Review of existing literature on T-cell involvement in AAV.
• Analysis of studies reporting T-cell activation markers in AAV patients.
• Examination of therapeutic strategies targeting T cells in AAV.

Main Results:

• Increased markers of T-cell activation are consistently found in AAV patients.
• T-cell activation persists during remission and despite treatment.
• Successful therapeutic outcomes have been reported with T cell-directed treatments.

Conclusions:

• Substantial evidence supports T-cell involvement in AAV pathogenesis, though mechanisms require further elucidation.
• Understanding the specific roles of different T-cell subsets (Th1/Th2, Treg, Tem) is crucial for targeted therapies.
• T-cell directed therapies show promise for managing AAV.